Pay in 4 interest-free payments of $6.98 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Retatrutide is an investigational triple incretin agonist (GLP-1, GIP, glucagon) not yet licensed by the MHRA or EMA in the UK
How GLP-1s Can Help Over a year after completing treatment, Id stand in my closet, furious at clothes that no longer fit and terrified of cancers continued hold on my body
Around 44% of users reported at least one side effect, most commonly gastrointestinal symptoms such as nauseaalready well documented in trials
Side Effect Monitoring Patients should be assessed for nausea, vomiting, gastrointestinal symptoms, and other adverse effects that could affect treatment or require clinical intervention
US$ 24.71
US$ 28.11
US$ 29.38
